Sanofi lifts 2014 guidance after Q2 earnings beat expectations

PARIS, July 31 (Reuters) - French drugmaker Sanofi raised its full-year guidance on Thursday after it posted stronger than expected quarterly earnings, driven by its rare disease business and higher sales in emerging markets.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.